Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.

Comparison of five antimicrobial regimens for treatment of mild to moderate inflammatory facial acne vulgaris in the community: randomised controlled trial

Open access
Ozolins, Mara, Eady, E Anne, Avery, Anthony J, Cunliffe, William J, Li Wan Po, Alain, O'Neill, Ciaran, Simpson, Nick B, Walters, Christina E, Carnegie, Ellen, Lewis, Jennifer B, Dada, John, Haynes, Mary, Williams, Karen, Williams, Hywel C · 2004 · The Lancet

Abstract

Background We investigated the efficacy and cost-effectiveness of five antimicrobial regimens for mild to moderate facial acne and whether propionibacterial antibiotic resistance affects treatment response. Methods In this randomised, observer-masked trial, 649 community participants were allocated one of five antibacterial regimens. Primary outcomes were patients' self-assessed improvement and reduction in inflamed lesions at 18 weeks. Analyses were by intention to treat. Findings Moderate or greater improvement at 18 weeks was reported in 72 (55%) of 131 participants assigned oral oxytetracycline plus topical placebo, 70 (54%) of 130 assigned oral minocycline plus topical placebo, 78 (60%) of 130 assigned topical benzoyl peroxide plus oral placebo, 84 (66%) of 127 assigned topical erythromycin and benzoyl peroxide in a combined formulation plus oral placebo, and 82 (63%) of 131 assigned topical erythromycin and benzoyl peroxide separately plus oral placebo. Most improvement occurred in the first 6 weeks. Treatment differences for the proportion of people with at least moderate improvement were: minocycline versus oxytetracycline -1.2% (unadjusted 95% CI -13.3 to 10.9); combined erythromycin and benzoyl peroxide versus oxytetracycline 11.1% (-0.7 to 22.9) and versus minocycline 12.3% (0.4 to 24.2); erythromycin and benzoyl peroxide separately versus combined formulation -3.5% (-15.2 to 8.2); benzoyl peroxide versus oxytetracycline 5.0% (-7.0 to 17.0), versus minocycline 6.2%…

Overview

Integrity signals

Registry

Crossref · 10.1016/s0140-6736(04)17591-0

Cites

25 of 25 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 25 references

Cited by

See all 181

Metadata

Authors
Ozolins, M., Eady, E. A., Avery, A. J., Cunliffe, W. J., Li Wan Po, A., O'Neill, C., Simpson, N. B., Walters, C. E., Carnegie, E., Lewis, J. B., Dada, J., Haynes, M., Williams, K., & Williams, H. C.
Affiliations
  • Queen's Medical Centre (GB)
  • University of Leeds (GB)
  • University of Nottingham (GB)
  • Leeds General Infirmary (GB)
  • Royal Victoria Infirmary (GB)
Corresponding author
Williams, Hywel C
Venue
The Lancet
Publisher
Elsevier BV
Published
2004-12
Volume
364
Issue
9452
Pages
2188-2195
ISSN
  • 0099-5355 (ISSN-L)
  • 0140-6736
OpenAlex
W2111319723
Cited by
168
References
25
Citations by year
2026: 1 · 2025: 1 · 2024: 4 · 2022: 8 · 2021: 6 · 2020: 5 · 2019: 5 · 2018: 4 · 2017: 7 · 2016: 9 · 2015: 9 · 2014: 11 · 2013: 10 · 2012: 8
FWCI
13.61
Type
journal article
Language
en
Open access
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations
  • The Lancet (publishedVersion)
  • PubMed (publishedVersion)
  • Aston Publications Explorer (Aston University) (submittedVersion)
  • Newcastle University ePrints (Newcastle Univesity)
Funders
Health Technology Assessment Programme
Topics
  • Health Sciences › Medicine › Dermatology › Acne and Rosacea Treatments and Effects
  • Health Sciences › Medicine › Dermatology › Dermatology and Skin Diseases
  • Health Sciences › Medicine › Infectious Diseases › Dermatological diseases and infestations
Keywords
acne, benzoyl peroxide, erythromycin, oxytetracycline, minocycline, tetracycline resistance, propionibacteria, cost-effectiveness, community-based treatment, treatment response
MeSH terms
Acne Vulgaris, Administration, Oral, Administration, Topical, Adolescent, Adult, Anti-Bacterial Agents, Benzoyl Peroxide, Child, Cost-Benefit Analysis, Erythromycin, Facial Dermatoses, Female, Humans, Male, Minocycline, Oxytetracycline, Skin, Single-Blind Method

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Comparison of five antimicrobial regimens for treatment of mild to moderate inflammatory facial acne vulgaris in the community: randomised controlled trial. https://app.cochat.ai/papers/10.1016/s0140-6736(04)17591-0
The paper
Ozolins, M., Eady, E. A., Avery, A. J., Cunliffe, W. J., Li Wan Po, A., O'Neill, C., Simpson, N. B., Walters, C. E., Carnegie, E., Lewis, J. B., Dada, J., Haynes, M., Williams, K., & Williams, H. C. (2004). Comparison of five antimicrobial regimens for treatment of mild to moderate inflammatory facial acne vulgaris in the community: randomised controlled trial. The Lancet. https://doi.org/10.1016/s0140-6736(04)17591-0

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.